Clinical Trial Update: Pharmacokinetic Study of Rezafungin in Patients With Suspected Intra-Abdominal Candidiasis [Phase 4]

View source ↗

Summary

A Phase 4 pharmacokinetic study of Rezafungin in patients with suspected intra-abdominal candidiasis (candidal peritonitis) is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidal Peritonitis
• Intra-abdominal Candidiasis

Drugs mentioned

• Rezafungin (rezafungin)

Snippet

Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | Conditions: Candidal Peritonitis | Phase 4 | Status: NOT_YET_RECRUITING